News

The global high potency active pharmaceutical ingredients market size is expected to be worth around US$ 44.8 billion by 2030, according to a new report by Vision Research Reports.

The global high potency active pharmaceutical ingredients market size was valued at US$ 24.4 billion in 2020 and is anticipated to grow at a CAGR of 20.3% during forecast period 2021 to 2030.

Report Coverage

Report Scope	Details
Market Size	USD 44.8 billion by 2030
Growth Rate	CAGR of 20.3% From 2021 to 2030
Base Year	2021
Historic Data	2017 to 2020
Forecast Period	2021 to 2030
Segments Covered	Product, Manufacturer,Drug Type, Application
Regional Scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned	Lonza, Novartis International AG, BASF AG, Carbogen Amcis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd Bristol-Myers Squibb, Pfizer Inc., Roche Diagnostics., Hospira Inc, Boehringer Ingelheim, Covidien Plc, Merck & Co, Bayer AG, Sigma-Aldrich Corporation, and Sanofi Aventis.

Get Sample Copy of This Report@https://www.visionresearchreports.com/report/sample/37899

Growth Factors

 Increasing number of new entrants producing fast relief therapeutics in emerging countries of India and China is anticipated to boost the demand for High potency active pharmaceutical ingredients (HPAPIs) over the forecast period.

In addition, supportive government regulations for commercialization and research and development of novel drug molecules are projected to drive the industry growth. Extensive capital investments required for development of production facility has lead to increase in contract manufacturing activities for HPAPIs during the forecast period.

Key Players

Lonza, Novartis International AG, BASF AG, Carbogen Amcis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd Bristol-Myers Squibb, Pfizer Inc., Roche Diagnostics., Hospira Inc, Boehringer Ingelheim, Covidien Plc, Merck & Co, Bayer AG, Sigma-Aldrich Corporation, and Sanofi Aventis.

Market Segmentation

• Product Outlook
  • Synthetic
  • Biotech
• Manufacturer Outlook
  • In-house
  • Outsourced
• Drug Type Outlook
  • Innovative
  • Generic
• Application Outlook
  • Oncology
  • Hormonal
  • Glaucoma
  • Others
• Regional Outlook
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • The Middle East and Africa
    • South Africa

Buy This Premium Research Report, click here@ https://www.visionresearchreports.com/report/cart/37899or call: +1 9197 992 333